Diferencia entre revisiones de «High altitude cerebral edema»

Sin resumen de edición
Línea 8: Línea 8:
**Progresses to [[coma]] if untreated  
**Progresses to [[coma]] if untreated  
*[[Headache]], [[nausea/vomiting]] (not always present)
*[[Headache]], [[nausea/vomiting]] (not always present)
*[[Focal neuro deficits]] may be seen (3rd/6th CN palsies)
*[[Focal neuro deficits]] may be seen ([[CN III palsy|3rd]]/[[abducens nerve palsy|6th]] CN palsies)
*[[Seizures]] are rare
*[[Seizures]] are rare


Línea 33: Línea 33:


==Prevention==
==Prevention==
*Acetazolamide 125mg BID (250mg BID if greater than 100kg)
*[[Acetazolamide]] 125mg BID (250mg BID if greater than 100kg)
*Dexamethasone 4mg q6h PO or IV
*[[Dexamethasone]] 4mg q6h PO or IV


==See Also==
==See Also==

Revisión del 19:06 28 sep 2019

Background

  • Also known as HACE
  • Progressive neurologic deterioration in someone with AMS or HAPE (due to ↑ ICP)
  • Almost never occurs at <8000ft

Clinical Features

Differential Diagnosis

High Altitude Illnesses

Evaluation

  • Clinical diagnosis

Management

High altitude management algorithm.
  • Immediate descent is the treatment of choice
  • If descent not possible use combination of:
    • Supplemental O2 (goal SpO2 90%)[1]
    • Supportive hyperventilation
    • Dexamethasone 8mg initially, then 4mg q6hr
    • Acetazolamide 250mg BID (better as ppx)
    • Hyperbaric bag (Gamow bag) if available

Prevention

See Also

References

  1. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol 2004; 5:136-146.